ACRES' Global Standards Initiative for Clinical Research Sites Advances
ACRES announced Phase 3 of its Site Accreditation and Standards Initiative
The Alliance for Clinical Research Excellence and Safety (ACRES), a multi-stakeholder non-profit collaborative building a global system to enhance safety, quality and efficiency in clinical research, announced Phase 3 of its Site Accreditation and Standards Initiative (SASI). The third phase of the project begins formal development of standards and metrics for site accreditation. Teams of 5-7 experts drawn from the global stakeholder community will develop standards in at least seven domains: personnel, facilities, management, information systems, quality management, recruitment and enrollment, and research integrity. Additional cross-cutting teams in specialty areas, such as first-in-man studies and pediatrics will also contribute their expertise. The Global Standards Excellence (GSE) Working Party will be responsible for coordinating and integrating the standards development process. ACRES ally, Essex Management, will provide project support. Amir H. Kalali, Vice-President, Global Head, Neuroscience Center of Excellence at Quintiles and Arti Bajpai, President, Compliance and Quality Integration (CQI) Consulting will lead the effort as co-chairs of the GSE Working Party that will include experts with expertise in all aspects of clinical research site management and operations, quality management, and regulatory oversight from around the world.
Read the full release here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
